Keyphrases
Osteoblast
100%
Saos-2
100%
Neutral Sphingomyelinase
100%
Native LDL
100%
Oxidized Low-density Lipoprotein (ox-LDL)
57%
Src Kinase
42%
Cell Death
42%
Scyphostatin
42%
Comorbidity
28%
Caspase-9
28%
Kinase Activity
28%
Akt Phosphorylation
28%
Glycogen Synthase Kinase 3 (GSK3)
28%
Caspase-8
28%
Forkhead
28%
Apoptosis
14%
Aging
14%
Phosphorylation
14%
Macrophages
14%
Downstream Targets
14%
Cell Proliferation
14%
Cell Survival
14%
Caspase-3
14%
Ceramide
14%
Growth Arrest
14%
Induced Apoptosis
14%
Pro-apoptotic
14%
Induced Cell Death
14%
Morphological Characteristics
14%
Etiological Factors
14%
Anti-apoptotic
14%
Bcl-x
14%
Vascular Wall
14%
Postmenopausal Osteoporosis
14%
Executor
14%
Mitochondrial Apoptotic Pathway
14%
Oxidized Low Density
14%
Osteoblast Growth
14%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Sphingomyelin Phosphodiesterase Inhibitor
100%
Receptor
66%
Caspase 9
66%
Glycogen Synthase Kinase 3
66%
Sphingomyelin Phosphodiesterase
66%
Comorbidity
66%
Caspase 3
33%
Caspase 8
33%
Etiology
33%
Growth Disorder
33%
Antiapoptotic
33%
Atherosclerosis
33%
Ceramide
33%
Postmenopause Osteoporosis
33%
Caspase 8 Inhibitor
33%
Biochemistry, Genetics and Molecular Biology
Osteoblast
100%
Acid Sphingomyelinase
100%
Sphingomyelin Phosphodiesterase
100%
Cell Death
80%
Phosphotransferase
60%
Kinase
60%
Caspase 8
40%
Caspase-9
40%
Saos-2 Cells
40%
Glycogen Synthase Kinase 3
40%
Comorbidity
40%
Morphology
20%
Cell Survival
20%
Cell Proliferation
20%
Macrophage
20%
Caspase 3
20%
Ceramide
20%